Effects of ethane-1 hydroxy-1, 1-Diphosphonate (5 mg/kg/day dose) onquantitative bone histology in paget's disease of bone

Alexandre, 1977, Le traitement de la maladie osseuse de Paget par I'Ethane-1 Hydroxy-1, 1 Dlphosphonate, Lyon, Ass. Corp. Et. Mod., 302 Alexandre, 1979, Traltement des paraplégies pagétiques par lea Diphosphonates. Premiers résultats, Rev. Neurol., 185, 625 Alexandre, 1980, Le traitement de la maladie osseuse de Paget par I'Ethane-1 Hydroxy-1, 1 Diphosphonate 8 taibie posologie, Nouv. Presse Med., 9, 3429 Altman, 1973, Influence of disodium etidronate on clinical and Laboratory manifestations of Paget's disease of bone (osteitis deformans), N. Engl. J. Med., 289, 1379, 10.1056/NEJM197312272892601 Bijvoet, 1978, Treatment of Paget's disease with combined calcitonin and diphosphonate (EHDP), Metab. Bone Dis. and Rel. Res., 1, 251, 10.1016/0221-8747(78)90010-3 Canfield, 1977, Diphosphonate Therapy of Paget's disease of bone, J. Clin. Endocrinol. Metab., 44, 96, 10.1210/jcem-44-1-96 Fleisch, 1969, Diphosphonate inhibit hydroxyapatits dissolution in vitro and bone resorption in tissue culture and in vivo, Science, 165, 1262, 10.1126/science.165.3899.1262 Frost, 1969, Tetracycline-based histological analysis of bone remodeling, Calcif. Tissue Res., 3, 211, 10.1007/BF02058664 Hosking, 1976, Paget's bone disease treated with diphosphonate and calcitonin, Lancet, i, 615, 10.1016/S0140-6736(76)90420-7 Jung, 1973, The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals, Calcif. Tissue Res., 11, 269, 10.1007/BF02547227 Khairi, 1974, Treatment of Paget's disease of bone (Osteltis deformans). Results of a one-year study, JAMA, 230, 562, 10.1001/jama.1974.03240040032027 Khairi, 1974, Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP), Clin. Orthop. related Res., 127, 94 Khairi, 1977, Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results, Ann. Intern. Med., 87, 656, 10.7326/0003-4819-87-6-656 Khairi, 1977, Quantitative bone histology in Paget's disease of bone : influence of sodium etidronate (EHDP) therapy, Calcif. Tissue Res., 22, 355, 10.1007/BF02064099 Meunier, 1975, Morphometric analysis of osteoid in iliac trabecular bone. Methodology, dynamical significance of the osteoid parameters, 149 Meunier, 1976, Morphometric analysis of trabecular resorption surfaces in normal iliac bone, 156 Meunier, 1977, Disturbances in morphology and dynamics of the remodeling process in pagetic bone, 78 Meunier, 1977, Dose-dependent effects of EHDP on dynamics of bone remodeling in Paget's disease studies in involved and non-involved areas, Calcif. Tissue Res., 24, R Meunier, 1979, Effects of disodium dichloromethylene diphosphonate (Cl2MDP) on Paget's disease of bone, Lancet, ii, 489, 10.1016/S0140-6736(79)91551-4 Meunier, 1980, Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of Pagetic and non-pagetic bone tissues, Arth. Rheum., 23, 1095, 10.1002/art.1780231005 Minkin, 1974, Bone remodeling in vitro : the effects of two diphosphonates on osteoid synthesis and bone resorption in mouse calvaria, Calcif. Tissue Res., 14, 161, 10.1007/BF02060292 Rebel, 1974, Anomalies nucléaires des ostéoclastes de la maladie osseuse de Paget, Nouv. Presse Méd., 20, 1299 Rows, 1976, The alteration of osteoclast morphology by diphosphonates in bone organ culture, Calcif. Tissue Res., 20, 53, 10.1007/BF02546397 Russell, 1973, Effects of diphosphonates and calcitonin on the chemistry and quantitative histology of rat bone, Calcif. Tissue Res., 11, 179, 10.1007/BF02547218 Russell, 1974, Diphosphonates in Paget's disease, Lancet, i, 894, 10.1016/S0140-6736(74)90347-X Ryan, 1970, Experiences in the treatment of Paget's disease of bone with mithramycin, JAMA, 213, 1153, 10.1001/jama.1970.03170330035004 Smith, 1973, Paget's disease of bone, Quart. J. Med., 42, 235 Woodhouse, 1972, Radiological regression in Paget's disease treated by human calcitonin, Lancet, 2, 992, 10.1016/S0140-6736(72)92404-X